EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation

Anne Doye iD, Paul Chaintreuil iD, Chantal Lagresle-Peyrou iD, Ludovic Batistic iD, Valentine Marion iD, Patrick Munro iD, Celine Loubatier iD, Rayana Chirara iD, Nataël Sorel iD, Boris Bessot iD, Pauline Bronnec iD, Julie Contenti iD und 14 weitere

Journal of Experimental Medicine · 2024

DOI: 10.1084/jem.20231562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Anne Doye und 25 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, INSERM, C3M , Nice, France. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, RAC2 GTP-Binding Protein, Gain of Function Mutation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Fondation pour la Recherche Médicale, Agence Nationale de la Recherche, E-Rare Joint Transnational Call for Proposals 2015.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A growing number of patients presenting severe combined immunodeficiencies attributed to monoallelic RAC2 variants have been identified. The expression of the RHO GTPase RAC2 is restricted to the hematopoietic lineage. RAC2 variants have been described to cause immunodeficiencies associated with high frequency of infection, leukopenia, and autoinflammatory features. Here, we show that specific RAC2 activating mutations induce the NLRP3 inflammasome activation leading to the secretion of IL-1β and IL-18 from macrophages. This activation depends on the activation state of the RAC2 variant and is mediated by the downstream kinase PAK1. Inhibiting the RAC2–PAK1–NLRP3 inflammasome pathway might be considered as a potential treatment for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesRAC2 GTP-Binding ProteinGain of Function MutationMacrophagesrac GTP-Binding ProteinsInterleukin-1betap21-Activated KinasesHumansAnimalsMiceInterleukin-18Signal Transduction

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsInterleukin-1betap21-Activated KinasesInterleukin-18PAK1 protein, humanNLRP3 protein, human

Autor:innen und Institutionen

  • Université Côte d'Azur, INSERM, C3M , Nice, France.
  • Université Paris Cité , Paris, France.
  • Imagine Institute, INSERM UMR 1163 , Paris, France.
  • Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM , Paris, France.
  • Université Côte d'Azur, Centre Hospitalier Universitaire de Nice , Nice, France.
  • Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111 , Lyon, France.

ORCID-Profile: Anne Doye, Paul Chaintreuil, Chantal Lagresle-Peyrou, Ludovic Batistic, Valentine Marion, Patrick Munro, Celine Loubatier, Rayana Chirara, Nataël Sorel, Boris Bessot, Pauline Bronnec, Julie Contenti, Johan Courjon, Valerie Giordanengo, Arnaud Jacquel, Pascal Barbry, Marie Couralet, Nathalie Aladjidi, Alain Fischer, Marina Cavazzana, Coralie Mallebranche, Orane Visvikis, Sven Kracker, Despina Moshous, Els Verhoeyen, Laurent Boyer

Förderung

  • Fondation pour la Recherche Médicale
  • Agence Nationale de la Recherche
  • E-Rare Joint Transnational Call for Proposals 2015
  • Association pour la Recherche sur le Cancer
  • Université Côte d'Azur
  • France Génomique National Infrastructure
  • Canceropôle PACA
  • Université Côte d’Azur

Zitieren

APA

Doye, A., Chaintreuil, P., Lagresle-Peyrou, C., Batistic, L., Marion, V., Munro, P., Loubatier, C., Chirara, R., Sorel, N., Bessot, B., Bronnec, P., Contenti, J., Courjon, J., Giordanengo, V., Jacquel, A., Barbry, P., Couralet, M., Aladjidi, N., Fischer, A., …, & Boyer, L. (2024). RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20231562

Vancouver

Doye A, Chaintreuil P, Lagresle-Peyrou C, Batistic L, Marion V, Munro P, et al. RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20231562

BibTeX
@article{Doye2024,
  author = {Doye, Anne and Chaintreuil, Paul and Lagresle-Peyrou, Chantal and Batistic, Ludovic and Marion, Valentine and Munro, Patrick and Loubatier, Celine and Chirara, Rayana and Sorel, Nataël and Bessot, Boris and Bronnec, Pauline and Contenti, Julie and Courjon, Johan and Giordanengo, Valerie and Jacquel, Arnaud and Barbry, Pascal and Couralet, Marie and Aladjidi, Nathalie and Fischer, Alain and Cavazzana, Marina and Mallebranche, Coralie and Visvikis, Orane and Kracker, Sven and Moshous, Despina and Verhoeyen, Els and Boyer, Laurent},
  title = {RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation},
  journal = {Journal of Experimental Medicine},
  year = {2024},
  doi = {10.1084/jem.20231562}
}
Kostenlos starten →